Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1990 1
1992 1
1993 1
1998 1
1999 1
2001 1
2003 2
2006 1
2007 3
2008 3
2009 7
2010 7
2011 3
2012 6
2013 10
2014 6
2015 7
2016 6
2017 4
2018 7
2019 8
2020 12
2021 11
Text availability
Article attribute
Article type
Publication date

Search Results

97 results
Results by year
Filters applied: . Clear all
Page 1
Vascular safety of erenumab for migraine prevention.
Kudrow D, Pascual J, Winner PK, Dodick DW, Tepper SJ, Reuter U, Hong F, Klatt J, Zhang F, Cheng S, Picard H, Eisele O, Wang J, Latham JN, Mikol DD. Kudrow D, et al. Among authors: klatt j. Neurology. 2020 Feb 4;94(5):e497-e510. doi: 10.1212/WNL.0000000000008743. Epub 2019 Dec 18. Neurology. 2020. PMID: 31852816 Free PMC article.
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study.
Reuter U, Goadsby PJ, Lanteri-Minet M, Wen S, Hours-Zesiger P, Ferrari MD, Klatt J. Reuter U, et al. Among authors: klatt j. Lancet. 2018 Nov 24;392(10161):2280-2287. doi: 10.1016/S0140-6736(18)32534-0. Epub 2018 Oct 22. Lancet. 2018. PMID: 30360965 Clinical Trial.
One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE study.
Goadsby PJ, Reuter U, Hallström Y, Broessner G, Bonner JH, Zhang F, Wright IK, Chou DE, Klatt J, Picard H, Lenz RA, Mikol DD. Goadsby PJ, et al. Among authors: klatt j. Neurology. 2020 Aug 4;95(5):e469-e479. doi: 10.1212/WNL.0000000000010019. Epub 2020 Jul 7. Neurology. 2020. PMID: 32636324 Free PMC article. Clinical Trial.
Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study.
Ashina M, Tepper S, Brandes JL, Reuter U, Boudreau G, Dolezil D, Cheng S, Zhang F, Lenz R, Klatt J, Mikol DD. Ashina M, et al. Among authors: klatt j. Cephalalgia. 2018 Sep;38(10):1611-1621. doi: 10.1177/0333102418788347. Epub 2018 Jul 8. Cephalalgia. 2018. PMID: 29984601 Clinical Trial.
Early onset of efficacy with erenumab in patients with episodic and chronic migraine.
Schwedt T, Reuter U, Tepper S, Ashina M, Kudrow D, Broessner G, Boudreau GP, McAllister P, Vu T, Zhang F, Cheng S, Picard H, Wen S, Kahn J, Klatt J, Mikol D. Schwedt T, et al. Among authors: klatt j. J Headache Pain. 2018 Oct 1;19(1):92. doi: 10.1186/s10194-018-0923-6. J Headache Pain. 2018. PMID: 30276500 Free PMC article. Clinical Trial.
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions.
Ashina M, Kudrow D, Reuter U, Dolezil D, Silberstein S, Tepper SJ, Xue F, Picard H, Zhang F, Wang A, Zhou Y, Hong F, Klatt J, Mikol DD. Ashina M, et al. Among authors: klatt j. Cephalalgia. 2019 Dec;39(14):1798-1808. doi: 10.1177/0333102419888222. Epub 2019 Nov 10. Cephalalgia. 2019. PMID: 31707815
Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study.
Goadsby PJ, Paemeleire K, Broessner G, Brandes J, Klatt J, Zhang F, Picard H, Lenz R, Mikol DD. Goadsby PJ, et al. Among authors: klatt j. Cephalalgia. 2019 Jun;39(7):817-826. doi: 10.1177/0333102419835459. Epub 2019 Apr 13. Cephalalgia. 2019. PMID: 30982348 Clinical Trial.
97 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page